Log in to save to my catalogue

Opposite response of lung adenocarcinoma and its choroidal metastases upon ramucirumab plus docetaxe...

Opposite response of lung adenocarcinoma and its choroidal metastases upon ramucirumab plus docetaxe...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2656975956

Opposite response of lung adenocarcinoma and its choroidal metastases upon ramucirumab plus docetaxel therapy after immunotherapy: a case report

About this item

Full title

Opposite response of lung adenocarcinoma and its choroidal metastases upon ramucirumab plus docetaxel therapy after immunotherapy: a case report

Publisher

Dordrecht: Springer Netherlands

Journal title

Angiogenesis (London), 2022-05, Vol.25 (2), p.147-149

Language

English

Formats

Publication information

Publisher

Dordrecht: Springer Netherlands

More information

Scope and Contents

Contents

We report a unique case of advanced non-small cell lung cancer that exhibited the opposite response to its unilateral choroidal metastases upon ramucirumab plus docetaxel treatment. A combination of cisplatin, pemetrexed, and pembrolizumab was administered as first-line treatment, resulting in shrinkage of all the lesions. However, although the pat...

Alternative Titles

Full title

Opposite response of lung adenocarcinoma and its choroidal metastases upon ramucirumab plus docetaxel therapy after immunotherapy: a case report

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2656975956

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2656975956

Other Identifiers

ISSN

0969-6970

E-ISSN

1573-7209

DOI

10.1007/s10456-021-09820-7

How to access this item